Chemotherapeutic strategies for renal cell carcinoma. Review uri icon

Overview

abstract

  • Metastatic renal cell carcinoma (RCC) is a disease that is highly resistant to systemic chemotherapy. Responses to combination chemotherapy have been reported in patients with collecting duct carcinoma and the sarcomatoid variant of renal cancer. Clinical trials combining chemotherapy with biologic response modifiers have not resulted in significant advances in the treatment of RCC. Patients with advanced local or metastatic RCC should be offered investigational therapeutic options. The identification of novel agents with significantly improved antitumor activity remains a high priority in the treatment of this disease.

publication date

  • August 1, 2003

Research

keywords

  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Identity

Scopus Document Identifier

  • 0042821661

Digital Object Identifier (DOI)

  • 10.1016/s0094-0143(03)00031-4

PubMed ID

  • 12953758

Additional Document Info

volume

  • 30

issue

  • 3